FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:287-289 July 26, 2001 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Srinivasan, A. PubMed Citation

Glanders is a zoonotic disease of horses and related equids that was eliminated from the United States in 1934. The etiologic agent, Burkholderia mallei, has occasionally caused severe infection in humans after the transmission of small aerosolized particles from infected animals, and B. mallei was used for biologic warfare, directed against the horses of the Allied armed forces, during World War I. Before the case reported by Srinivasan et al. in this issue of the Journal,¹ the last infections in humans in the United States occurred in 1945 among laboratory personnel working on a biologic-weapons program at Camp Detrick, Maryland.² . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Margolis, D. A., Burns, J., Reed, S. L., Ginsberg, M. M., O'Grady, T. C., Vinetz, J. M. (2008). Septicemic Plague in a Community Hospital in California. Am J Trop Med Hyg 78: 868-871 [Abstract] [Full Text]  
• Lim, D. V., Simpson, J. M., Kearns, E. A., Kramer, M. F. (2005). Current and Developing Technologies for Monitoring Agents of Bioterrorism and Biowarfare. Clin. Microbiol. Rev. 18: 583-607 [Abstract] [Full Text]  
• O'Hara, C. M. (2005). Manual and Automated Instrumentation for Identification of Enterobacteriaceae and Other Aerobic Gram-Negative Bacilli. Clin. Microbiol. Rev. 18: 147-162 [Abstract] [Full Text]  
• Wynia, M. K., Gostin, L. O. (2004). Ethical Challenges in Preparing for Bioterrorism: Barriers Within the Health Care System. AJPH 94: 1096-1102 [Abstract] [Full Text]  
• Pavlin, J. A., Mostashari, F., Kortepeter, M. G., Hynes, N. A., Chotani, R. A., Mikol, Y. B., Ryan, M. A. K., Neville, J. S., Gantz, D. T., Writer, J. V., Florance, J. E., Culpepper, R. C., Henretig, F. M., Kelley, P. W. (2003). Innovative Surveillance Methods for Rapid Detection of Disease Outbreaks and Bioterrorism: Results of an Interagency Workshop on Health Indicator Surveillance. AJPH 93: 1230-1235 [Abstract] [Full Text]  
• Kahan, E., Fogelman, Y., Kitai, E., Vinker, S. (2003). Patient and family physician preferences for care and communication in the eventuality of anthrax terrorism. Fam Pract 20: 441-442 [Abstract] [Full Text]  
• Hupert, N., Mushlin, A. I., Callahan, M. A. (2002). Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers. Med Decis Making 22: S17-S25 [Abstract]  
• Hodge, J. G. Jr. (2002). Bioterrorism Law and Policy: Critical Choices in Public Health. J Law Med Ethics 30: 254-261  
• Rokach, A., Libow, L. S., Dykers, J. R. Jr., Campion, E. W., Drazen, J. M. (2002). The Acts of Terrorism. NEJM 346: 539-539 [Full Text]  
• Cohen, H. W., Sidel, V. W., Gould, R. M. (2001). Preparedness for Bioterrorism?. NEJM 345: 1423-1424 [Full Text]